Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Too Little Sleep Might Raise a Woman's Odds for Diabetes

Women who don t get enough sleep might have an increased risk of diabetes, an effect even more pronounced in postmenopausal females, a new study finds. Shorteni

COVID Rebound Occurs in 1 in 5 People Taking Paxlovid

Paxlovid helps prevent severe COVID-19, but it also might significantly increase a person s risk of a rebound case, a new study confirms. About 1 in 5 people ta

Most Kids With the Flu Miss Out on Antiviral Tamiflu

Children stricken with influenza aren t receiving the flu-busting antiviral drug Tamiflu even though it s recommended for them, a new study says. Three of five

More Than 1 in 6 U.S. Adults, Teens Have Substance Use Disorder

Over 1 in 6 Americans, adults and teens alike, suffered a substance use disorder in 2022, new government data released Monday shows. including about 6 million w

Many Clinics Are Selling Ketamine as Bogus 'Cure' for Illnesses

The party drug and anesthetic ketamine is starting to show promise in trials as a treatment for depression. But new research also suggests that hundreds of U.S.

American Academy of Ophthalmology, Nov. 3-5

The annual meeting of the American Academy of Ophthalmology was held from Nov. 3 to 5 in San Francisco and attracted participants from around the world, includi

Gender Life Expectancy Gap Increased From 2010 to 2021

From 2010 to 2021, the gender life expectancy gap increased, with COVID-19 the leading contributor from 2019 to 2021, according to a research letter published o

FDA Approves First Treatment for Congenital Thrombotic Thrombocytopenic Purpura

The U.S. Food and Drug Administration has approved Adzynma, the first recombinant protein product indicated for prophylactic or on-demand enzyme replacement the

AHA: Fresh Produce Prescription Improves Glycemic Control

A fresh produce prescription program can significantly improve hemoglobin A1c (HbA1c) among low-income patients with diabetes and poor glycemic control, accordi

AHA: Semaglutide Cuts Risk for CVD Events in Patients Without Diabetes

Weekly subcutaneous semaglutide significantly cuts the incidence of cardiovascular death and nonfatal heart attacks and strokes in adults with preexisting cardi

Popular Keywords